Direct-to-Patient Growth ixlayer is expanding DTP healthcare platforms and has recently launched Informed Pain Care to widen digital acute pain evaluation nationwide. Potential sales opportunity: position with biopharma and payer organizations seeking to accelerate patient access, adherence, and outcomes through cloud-based DTP solutions.

Strategic Partnerships Recent collaborations include a partnership with Vertex Pharmaceuticals to deliver a digital solution for acute pain management. Sales angle: target pharma and biotech companies exploring integrated digital health solutions to support clinical programs, patient engagement, and real-world evidence generation.

Awards and Recognition Multiple industry awards for healthcare technology innovation and DEI demonstrate credibility and market validation. Sales takeaway: leverage these accolades in proposals to large biopharma and health tech prospects seeking trusted, award-winning technology partners.

Growth Leadership Executive leadership changes, including the appointment of a new General Manager in 2026, indicate organizational growth and strategic focus. Opportunity: engage with decision-makers on scale-up opportunities, enterprise deployments, and customer success programs across global pharmaceutical clients.

MarketPositioning Positioned as a cloud-based platform integrating with diverse systems to improve efficiency, patient access, and outcomes, with a notable emphasis on biopharma collaboration and compliance. Sales angle: pitch to pharma and diagnostics players seeking interoperable, compliant platforms that streamline digital trials, commercialization, and patient engagement.